Management of Lead Poisoning

Evaluarea și diagnosticul

The primary diagnostic test for lead poisoning is the blood lead level (BLL) test, which is used to assess the level of lead in the blood 2
Measuring serum creatinine can help identify individuals with chronic kidney disease who may be at increased risk due to lead exposure 2
Abdominal radiography should be considered for children with pica behavior or excessive insertion of objects into the mouth 3

For adults with a BLL ≥100 μg/dL, chelation therapy is indicated, and for those with a BLL of 80-99 μg/dL, chelation therapy should be considered regardless of symptoms, or for those with a BLL of 50-79 μg/dL if symptoms are present 1
The American College of Physicians recommends that adults with a BLL of 80-99 μg/dL should be considered for chelation therapy, and those with a BLL ≥100 μg/dL should receive urgent medical evaluation and chelation therapy 4, 1

For children with a BLL of 5-14 μg/dL, confirmation with a venous sample is recommended, and retesting of venous blood lead levels should be done in 1-3 months 5, 3
The American Academy of Pediatrics recommends that children with a BLL >44 μg/dL should have confirmation of blood lead level with a venous sample repeated in 48 hours, and consideration of hospitalization or chelation therapy 3

For severe lead poisoning (BLL ≥100 μg/dL or encephalopathy), calcium disodium ethylenediaminetetraacetic acid (CaNa₂EDTA) intravenously is recommended 1

Pregnant women should avoid lead exposure that would result in a BLL >5 μg/dL, and calcium supplementation during pregnancy is particularly important for women with prior lead exposure 2, 1
The Centers for Disease Control and Prevention recommend that breastfeeding should be encouraged for most women, with decisions for those with very high lead exposure being addressed individually 4, 1

For BLL 10-19 μg/dL, testing every 3 months is recommended, and for BLL ≥20 μg/dL, monthly testing is recommended until levels decrease 4, 1

A single BLL does not reflect cumulative body burden or predict long-term effects, and laboratory variability means that small changes in lead levels may not represent real increases or decreases 1, 5
Chelation therapy has been associated with improvement in symptoms and reduction in mortality in patients with lead encephalopathy, but controlled clinical trials demonstrating efficacy are lacking 1
No treatment has been shown to reverse the developmental effects of lead toxicity, making prevention crucial 1, 5